DENIS CHEM LAB
|
DENIS CHEM LAB Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 5.82 | 8.04 | 5.66 | 4.51 | 1.63 |
| CEPS(Rs) | 10.76 | 13.04 | 11.30 | 8.66 | 5.93 |
| DPS(Rs) | 1.50 | 2.50 | 2.00 | 1.50 | 0.75 |
| Book NAV/Share(Rs) | 61.33 | 57.91 | 52.08 | 47.89 | 44.32 |
| Tax Rate(%) | 27.32 | 26.28 | 28.00 | 29.50 | 26.65 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 9.30 | 12.65 | 11.68 | 10.51 | 9.38 |
| EBIT Margin(%) | 6.71 | 9.34 | 7.19 | 7.06 | 4.25 |
| Pre Tax Margin(%) | 6.41 | 9.02 | 6.79 | 6.51 | 2.82 |
| PAT Margin (%) | 4.66 | 6.65 | 4.89 | 4.59 | 2.07 |
| Cash Profit Margin (%) | 8.62 | 10.79 | 9.75 | 8.80 | 7.52 |
| Performance Ratios | |||||
| ROA(%) | 7.29 | 10.69 | 8.03 | 6.64 | 2.39 |
| ROE(%) | 9.76 | 14.62 | 11.33 | 9.79 | 3.76 |
| ROCE(%) | 13.89 | 20.15 | 16.07 | 13.79 | 6.50 |
| Asset Turnover(x) | 1.56 | 1.61 | 1.64 | 1.45 | 1.15 |
| Sales/Fixed Asset(x) | 1.50 | 1.57 | 1.59 | 1.39 | 1.16 |
| Working Capital/Sales(x) | 3.90 | 3.98 | 4.57 | 4.88 | 4.66 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.67 | 0.64 | 0.63 | 0.72 | 0.87 |
| Receivable days | 65.58 | 68.40 | 71.57 | 86.49 | 113.29 |
| Inventory Days | 21.06 | 21.00 | 21.57 | 25.39 | 29.45 |
| Payable days | 81.27 | 83.39 | 82.06 | 89.23 | 111.66 |
| Valuation Parameters | |||||
| PER(x) | 15.92 | 18.76 | 11.26 | 15.10 | 22.89 |
| PCE(x) | 8.61 | 11.56 | 5.65 | 7.87 | 6.30 |
| Price/Book(x) | 1.51 | 2.60 | 1.22 | 1.42 | 0.84 |
| Yield(%) | 1.62 | 1.66 | 3.14 | 2.20 | 2.01 |
| EV/Net Sales(x) | 0.60 | 1.10 | 0.46 | 0.65 | 0.51 |
| EV/Core EBITDA(x) | 5.58 | 8.19 | 3.79 | 5.78 | 5.27 |
| EV/EBIT(x) | 8.88 | 11.82 | 6.36 | 9.23 | 12.05 |
| EV/CE(x) | 1.20 | 2.28 | 0.99 | 0.92 | 0.61 |
| M Cap / Sales | 0.74 | 1.25 | 0.55 | 0.69 | 0.47 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 3.26 | 4.34 | 17.79 | 24.92 | -19.71 |
| Core EBITDA Growth(%) | -18.29 | 16.77 | 25.82 | 45.27 | -30.65 |
| EBIT Growth(%) | -25.86 | 35.64 | 19.89 | 107.72 | -46.15 |
| PAT Growth(%) | -27.61 | 41.93 | 25.50 | 176.59 | -46.26 |
| EPS Growth(%) | -27.61 | 41.94 | 25.50 | 176.59 | -46.27 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.01 | 0.01 | 0.03 | 0.05 | 0.14 |
| Current Ratio(x) | 2.70 | 2.55 | 2.46 | 2.11 | 1.93 |
| Quick Ratio(x) | 2.32 | 2.18 | 2.08 | 1.72 | 1.57 |
| Interest Cover(x) | 22.77 | 28.86 | 18.02 | 12.74 | 2.99 |
| Total Debt/Mcap(x) | 0.01 | - | 0.02 | 0.03 | 0.17 |
Compare Financial Ratios of peers of DENIS CHEM LAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DENIS CHEM LAB | ₹127.4 Cr | 1% | -2.8% | -39.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,822.0 Cr | 1.6% | 8.2% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,811.0 Cr | -0.8% | 14.4% | 12.2% | Stock Analytics | |
| CIPLA | ₹127,688.0 Cr | -3.9% | 5.5% | 5.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,840.0 Cr | -0.5% | 1% | 7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,544.0 Cr | -2.1% | -0% | -2% | Stock Analytics | |
DENIS CHEM LAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DENIS CHEM LAB | 1% |
-2.8% |
-39.8% |
| SENSEX | 0.7% |
4.7% |
6.1% |
You may also like the below Video Courses
